Takotsubo Cardiomyopathy Vs HOCM

Takotsubo Cardiomyopathy vs Obstructive Hypertrophic Cardiomyopathy (HOCM)

Takotsubo Cardiomyopathy Vs HOCM

Takotsubo cardiomyopathy, also known as stress-induced or “broken heart” cardiomyopathy, typically occurs after intense emotional or physical stress leading to a surge in catecholamines. It causes transient left ventricular dysfunction, most characteristically apical ballooning with basal hyperkinesis on echocardiography. The left ventricle usually has normal wall thickness, and any left ventricular outflow tract (LVOT) obstruction, if present, is mild or transient. Coronary angiography reveals normal coronary arteries, and left ventricular function generally recovers within days to weeks. On ECG, Takotsubo may mimic acute myocardial infarction with ST-segment elevation, deep T-wave inversions, and QT prolongation. Prognosis is usually favorable once the stress trigger is resolved.

In contrast, obstructive hypertrophic cardiomyopathy (HOCM) is a chronic, genetic disorder caused by sarcomeric gene mutations leading to asymmetric septal hypertrophy. This thickening produces a fixed or dynamic LVOT obstruction due to systolic anterior motion (SAM) of the mitral valve. Echocardiography shows a hypertrophied basal septum, a resting or provoked LVOT gradient greater than 30 mmHg, and dynamic mitral regurgitation. The ejection fraction is often normal or hyperdynamic. ECG findings typically include voltage criteria for left ventricular hypertrophy and deep, narrow Q waves in inferior and lateral leads. Unlike Takotsubo, the structural changes in HOCM are permanent and may predispose to arrhythmias and sudden cardiac death.

In summary, Takotsubo represents a transient “stunned” ventricle after stress with reversible apical ballooning, while obstructive HCM represents a genetically “thickened” heart with persistent LVOT obstruction. In simple terms: Takotsubo is the broken heart; HOCM is the thick heart.

Comments

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts. The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Dr. Usman's Cardiology Notes

Search This Blog